Barings’s Magellan Health Services, Inc. MGLN Stock Holding History

Barings’s Portfolio MGLN Stock Details MGLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-55,000	Closed	-$3.8M	–	1009
2017 Q1	$3.8M	Buy	+55,000	New	+$4.02M	0.04%	400

Other funds holding MGLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Barings's MGLN Position: Q2 2017 in Review

Barings sold out of Magellan Health Services, Inc. (MGLN) in Q2 2017, closing a stake of 55,000 shares — an estimated $3.8M sold.

Barings first reported a position in MGLN in Q1 2017 and held it in 1 quarter. The position peaked at $3.8M in Q1 2017. 194 funds tracked by Wall St. Rank hold MGLN as of Q2 2017.

Barings reported no remaining Magellan Health Services, Inc. position as of Q2 2017 after selling out during the quarter.
Barings sold 55,000 Magellan Health Services, Inc. shares in Q2 2017, an estimated $3.8M.
Barings first reported a position in Magellan Health Services, Inc. in Q1 2017 and held it in 1 quarter.
Barings's Magellan Health Services, Inc. position peaked at $3.8M in Q1 2017.
194 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q2 2017.

Based on Barings's 13F filing for Q2 2017, filed 14 Aug 2017.